Journal
ANALYTICA CHIMICA ACTA
Volume 713, Issue -, Pages 7-22Publisher
ELSEVIER
DOI: 10.1016/j.aca.2011.11.041
Keywords
Erythropoietin (EPO); Capillary electrophoresis; High performance liquid chromatography; Mass spectrometry; Doping control; EPO biosimilars
Categories
Funding
- Spanish Ministry of Science and Innovation [PCI2006-A7-0646, CTQ2009-09399]
- Spanish National Research Council (CSIC)
Ask authors/readers for more resources
Human erythropoietin (hEPO), a hormone involved in the formation of red blood cells, is a 30 kDa glycoprotein with a high carbohydrate content. The production of recombinant hEPO has made possible its widespread therapeutic use and its banned use in competition sports. Methods to analyze EPO and other erythropoiesis stimulating agents (ESAs) are necessary for the characterization and quality control of these biopharmaceuticals and also for doping control. In this paper, high resolution separation methods, namely high performance liquid chromatography (HPLC) and capillary electrophoresis (CE), with special attention to CE-coupled mass spectrometry, are reviewed. The usefulness of these techniques when applied in different modes to separate the glycoprotein isoforms, aggregates or excipients are detailed. In addition, sample preparation methods that have been applied to ESA samples for subsequent determination by HPLC or CE, as well as the potential compatibility of other preparation methods, are discussed. Applications of the HPLC and CE methods regarding regulatory considerations for biopharmaceuticals analysis, with emphasis on biosimilars, and doping control are also included. Finally, limitations of the present methods and their possible solutions are considered. (C) 2011 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available